People: Prometic Life Sciences Inc (PLI.TO)
18 Jul 2019
Mr. Andrew Bishop serves as Independent Director of the Company. Mr. Andrew Bishop is a Partner and Co-Founder of Bingley Capital Inc., and brings over 20 years of experience in advising biotech and health care companies. He has worked on over 100 financing and M&A transactions over his career. Prior to establishing Bingley Capital in 2009, he held senior roles in investment banking, including Head of Health Care Investment Banking at HSBC Securities (Canada) Inc., where he covered biotech, pharma, and specialty pharma companies. He started his career in investment banking focused on companies in Quebec. For the past nine years, Mr. Bishop served as a Director and Chair of Willow Breast & Hereditary Cancer Support, a not-for-profit organization focused on breast and hereditary cancer. Mr. Bishop received an International M.B.A. (with Distinction) from the Schulich School of Business at York University, and a Bachelor of Arts in Political Science and Economics from McGill University. He also received his Chartered Financial Analyst designation.
|Total Annual Compensation, CAD||53,850|
|Restricted Stock Award, CAD||--|
|Long-Term Incentive Plans, CAD||--|
|All Other, CAD||84,409|
|Fiscal Year Total, CAD||138,259|